ID

21158

Beschreibung

A Retrospective Case-Control Study to Estimate the Sensitivity and Specificity of a Pharmacogenetic Marker (HLA-B*5701) in Subjects With and Without Hypersensitivity to Abacavir Assessment: Inform Screening NCT00373945 / VIIV-ABC107442 Annotated Design For Trial:abc442_lgm Protocol:ABC107442 Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus I, Phase: 4, Clinical Study ID: ABC107442, Sponsor: ViiV

Stichworte

  1. 12.04.17 12.04.17 -
Hochgeladen am

12. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

HLA-B*5701 And Hypersensitivity To Abacavir Inform Screening NCT00373945

HLA-B*5701 And Hypersensitivity To Abacavir Inform Screening NCT00373945

Inform Screening
Beschreibung

Inform Screening

Alias
UMLS CUI-1
C1710477
Subject initials
Beschreibung

Subject initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Date of birth
Beschreibung

Date of birth

Datentyp

date

Alias
UMLS CUI [1]
C0421451
What is the primary method that prompted the subject's interest in the study?
Beschreibung

interest in the study

Datentyp

integer

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0543488
UMLS CUI [1,3]
C0392360
Was this subject a screen failure?
Beschreibung

screen failure

Datentyp

text

Alias
UMLS CUI [1]
C1710476
Was this subject a screen failure? Yes, select primary reason:
Beschreibung

primary reason for screen failure

Datentyp

integer

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0392360
primary reason for screen failure
Beschreibung

If other, please specify

Datentyp

text

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0392360

Ähnliche Modelle

HLA-B*5701 And Hypersensitivity To Abacavir Inform Screening NCT00373945

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inform Screening
C1710477 (UMLS CUI-1)
Subject initials
Item
Subject initials
text
C2986440 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
What is the primary method that prompted the subject's interest in the study?
integer
C0008976 (UMLS CUI [1,1])
C0543488 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
What is the primary method that prompted the subject's interest in the study?
CL Item
Clinic patient (site actively reviews patient charts and/or databases and initiates contact with patient). (1)
CL Item
Physician referral (e.g., lunch-n-learn, letter to colleagues, etc.) (2)
CL Item
Referred by family member (3)
CL Item
Referred by study participant (4)
CL Item
Subject-initiated internet search (e.g. discovered findclinicalstudy.com) (5)
CL Item
Other internet provider paid by GSK (e.g., harrisinteractive.com), specify (6)
CL Item
Information in clinic (e.g., posters, brochure, etc.) (7)
CL Item
Community outreach (e.g., healthfair, advocacy groups, support groups, etc.) (8)
CL Item
Call center (16)
CL Item
Other, specify (OT)
Item
Was this subject a screen failure?
text
C1710476 (UMLS CUI [1])
Code List
Was this subject a screen failure?
CL Item
No (N)
CL Item
Yes (Y)
Item
Was this subject a screen failure? Yes, select primary reason:
integer
C1710476 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Code List
Was this subject a screen failure? Yes, select primary reason:
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Non-compliance (8)
CL Item
Other, specify (OT)
primary reason for screen failure
Item
primary reason for screen failure
text
C1710476 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video